Chinas first fluoroquinolone drug sensitivity test standard published. YunDing Xinyao (01952.HK) Ilera helps take a crucial step in solving the dilemma of multi-drug resistant bacterial infections.

According to the Wise Finance and Economics APP, on June 23, 2025, Hong Kong-listed innovative pharmaceutical company YunDingXinYao (01952.HK) announced that the "Guidelines for in vitro Drug Sensitivity Testing of Erythromycin (2025)" (hereinafter referred to as the "Guidelines") has been published in the "Chinese Journal of Laboratory Medicine".